Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × gallium Ga 68 dotatate × 90 days × Clear all

Sponsor

Conditions

Pheochromocytoma 2 Paraganglioma 2 Neuroendocrine Tumors 2 Meningioma 2 von Hippel-Lindau Disease 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Neuroendocrine Prostate Cancer 1 Hypertension 1 Ganglioneuroma 1 Ganglioneuroblastoma 1 Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 55 Cisplatin 35 Cetuximab 26 Carboplatin 24 Radiotherapy 18 Radiotherapy, Intensity-Modulated 17 Magnetic Resonance Spectroscopy 16 Specimen Handling 14 Paclitaxel 14 Nivolumab 14 Docetaxel 14 Platinum 8 Fluorouracil 8 1,2-diaminocyclohexaneplatinum II citrate 8 Biopsy 6 (225)Ac-DOTA-c(RGDyK) 6 atezolizumab 5 Radiation 5 Ipilimumab 5 Drug Therapy 5 durvalumab 4 cemiplimab 4 Taxes 4 Standard of Care 4 Radiosurgery 4 Immunoglobulin G 4 Immune Checkpoint Inhibitors 4 Cyclophosphamide 4 Chemoradiotherapy 4 toripalimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡